Pharmosa Biopharm Inc
TPEX:6875
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pharmosa Biopharm Inc
TPEX:6875
|
TW |
|
Redde Northgate PLC
LSE:REDD
|
UK |
|
J
|
J D Wetherspoon PLC
F:0QW
|
UK |
|
C
|
CPPGroup PLC
F:4CV1
|
UK |
|
A
|
Alar Pharmaceuticals Inc
TPEX:6785
|
TW |
|
X
|
Xu Yuan Packaging Technology Co Ltd
TPEX:8421
|
TW |
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
S
|
SoulBrain Holdings Co Ltd
KOSDAQ:036830
|
KR |
|
A
|
ADATA Technology Co Ltd
TPEX:3260
|
TW |
|
E
|
Eagle Veterinary Technology Co Ltd
KOSDAQ:044960
|
KR |
Shareholder Yield
Current shareholder yield for Pharmosa Biopharm Inc is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Pharmosa Biopharm Inc
| Average Annual Return | 11.55% |
| Standard Deviation of Annual Returns | 43.75% |
| Max Drawdown | -76% |
| Market Capitalization | 4.3B TWD |
| Shares Outstanding | 129 180 000 |
| Percentage of Shares Shorted |
N/A
|
